Terpene-based formulation for preventing intramammary infections

A terpene-based dip effectively prevents and treats intramammary infections in dairy cattle by targeting S. aureus and E. coli, overcoming iodine's limitations with reduced skin irritation and maintaining efficacy in the presence of organic matter, thereby reducing economic losses.

WO2026232247A1PCT designated stage Publication Date: 2026-11-12KIEFTER SPA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/CL2026/050074
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-08
Filing Date
2026-05-08
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Current treatments for intramammary infections in dairy cattle, such as iodine-based dips, are ineffective against pathogens like Staphylococcus aureus, cause skin irritation, and are inactivated by organic matter, leading to recurrent infections and economic losses.

Method used

A terpene-based formulation comprising alpha-terpineol, thymol, and limonene, derived from turpentine, is used as a post-milking dip to prevent and treat intramammary infections, effective against S. aureus and E. coli, and maintains efficacy in the presence of organic matter.

Benefits of technology

The terpene dip effectively reduces bacterial load, prevents biofilm formation, and maintains skin health, reducing somatic cell counts and new infection incidence, with no skin irritation and low toxicity, thus minimizing economic losses.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000010_0001_TABLE
    Figure IMGF000010_0001_TABLE
  • Figure IMGF000011_0001_TABLE
    Figure IMGF000011_0001_TABLE
  • Figure 00000025_0000
    Figure 00000025_0000
Patent Text Reader

Abstract

The present invention relates to: a terpene-based formulation with antibacterial activity, which is used as post-milking dip to prevent and treat intramammary and skin infections; a method; and a use of the formulation, which can be used on mammals, mainly in agriculture.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] SOIL-BASED FORMULATION FOR THE PREVENTION OF INTRAMAMMARY INFECTIONS FIELD OF THE INVENTION

[0002] The present invention relates to a terpene-based formulation with antibacterial activity, which is used as a dipping agent in the prevention and treatment of intramammary and skin infections, and can be used in mammals, mainly in the agricultural area.

[0003] STATE OF THE ART

[0004] Intramammary Infection (IMI), which leads to mastitis, is considered a common disease in the agricultural sector, primarily affecting dairy cattle worldwide. It has a significant impact due to decreased milk production and alterations in its properties and components, thus affecting its quality and, consequently, its marketability. As a result, cows diagnosed with this condition have a higher risk of being culled, and in severe cases, it can even cause the animal's death, increasing replacement costs. It is estimated that 70% of economic losses on a production unit are due to this problem.

[0005] Infectious mastitis (IM) causes an inflammatory reaction in the mammary gland, producing physical and chemical alterations in the milk, an increase in the number of somatic cells due to the presence of pathogenic microorganisms, and ultimately, changes such as loss of function. This inflammatory reaction occurs as a consequence of the tissues' response to traumatic injuries, irritants, or the presence of infectious agents and their toxins that have colonized the secretory tissue. From a symptomatic standpoint, mastitis is divided into clinical and subclinical forms. In the clinical presentation, the affected mammary quarter, or even the entire udder, becomes inflamed, painful, and edematous. The milk contains clots and lumps and turns yellow or reddish due to the presence of pus or blood. In severe cases, the cow experiences fever, increased pulse, lethargy, loss of appetite, and a decrease in milk production.

[0006] The subclinical form is characterized by the absence of clinical signs in the udder and the normal appearance of the milk. The greatest economic impact occurs in the subclinical forms, where the various etiological agents increase the number of somatic cells, resulting in a decrease in milk production.

[0007] Among the important microorganisms found in milk infections are Staphylococcus aureus and Escherichia coli. These pathogens can be found in the udder, in skin lesions of the teats, on the hands of milkers, in bedding, on milking equipment, etc. Often, handling practices can allow these microorganisms to reach the teat canal and trigger an inflammatory reaction.

[0008] On the other hand, infection with these germs also occurs through the use of contaminated milking equipment and neglect of preventative measures such as poor teat hygiene (washing or pre-dipping) and failure to properly seal the teats. Poor livestock practices in implementing preventative measures can allow some of these microorganisms to develop systemic symptoms in the cow and cause death.

[0009] As for treatments for IIM, these mainly include antibiotics.

[0010] The general benefits of antibiotic therapy are that it promotes rapid recovery, decreases the likelihood of recurrent infections, can significantly reduce losses in milk production, and can prevent animal death. However, there are several reasons why therapy may not be effective in affected animals. One is that the selected antibiotic is not appropriate, resulting in ineffective elimination of the infection, or, for example, the active ingredient is affected by the presence of organic matter. Another factor is that the antibiotics are not administered correctly, in terms of dosage and duration. In other cases, the treatment is effective, but proper hygiene measures are not followed, leading to a recurrence of the disease. Finally, combination therapy with the wrong antibiotics can cause an antagonistic effect.

[0011] Current control measures are based on a proper milking routine and process that involves a series of activities such as disinfecting teats before and after milking, maintaining equipment, early detection and medication of affected cows, implementing dry cow therapy programs, and culling chronic cases. Preventive measures for intramammary insufficiency (IMI) aim to prevent bacterial proliferation in the teat, especially after milking, where milk remains (a source of bacterial nutrition) and the teat canal is open, as the keratin plug takes between half an hour and an hour to form. Prevention, in turn, avoids the spread to other cows, restores milk production, reduces the recurrence of the problem, prevents irreversible damage to mammary gland tissue, and improves the health and well-being of affected cows.

[0012] Among these preventative measures, "dipping" or post-milking disinfection is a practice used to prevent intra-milk infections (IMIs) in cattle. Dipping involves immersing the teats in an antiseptic solution after each milking to eliminate bacteria that can cause infection.

[0013] The importance of dipping lies in the fact that it helps prevent bacteria from entering the mammary gland through the nipples, reducing the likelihood of developing an intramammary infection.

[0014] Furthermore, the disinfectant solution eliminates any bacteria that may remain on the skin and teat end after milking, improving udder health. By reducing the incidence of mastitis, dipping contributes to better udder health in cows, which in turn improves the quality and quantity of milk produced. While dipping can be a solution for preventing bovine mastitis, gel-type solutions are also available for better adherence. Most current commercial formulations use iodine as the main component, which can cause significant irritation and does not effectively control the incidence of new cases, for example, in the case of Staphylococcus aureus.

[0015] Based on the above, efforts have now been made to obtain products of natural and effective origin.

[0016] The search for products containing natural active ingredients is an active area of ​​research, and various options are being explored.

[0017] It is crucial to keep in mind that, although these products contain natural active ingredients that have antimicrobial properties, the scientific evidence is often limited, and their effectiveness may vary; however, products that are more natural and environmentally friendly continue to be manufactured on the market.

[0018] Regarding the status of industrial property, the following documents were found related to the technology that is to be protected.

[0019] European patent EP2138171 relates to therapeutically effective terpinen-4-ol-based compositions with a broad spectrum of activity against a wide range of mastitis-causing bacteria of the genera Staphylococcus spp., Streptococcus spp., Escherichia spp., Enterococcus spp., Serratia spp., Klebsiella spp., and Aeromosa spp. Methods for preventing, treating, and controlling mastitis in dairy animals and for reducing its spread in dairy herds are described.

[0020] US Patent 2011223114 relates to an antimicrobial composition for cleaning or personal care. The object of the present invention is to provide antimicrobial compositions with a relatively rapid antimicrobial action, wherein said compositions contain selected ingredients, such as thymol and terpineol, in predetermined selective proportions. US Patent 20190117538 describes an antimicrobial composition, and more specifically an antimicrobial composition for rinse-free applications. The present invention describes an antimicrobial composition comprising: a) 0.01 to 2% by weight of thymol; b) 0.01 to 2% by weight of terpineol; and c) 0.1 to 2% by weight of a cationic phospholipid complex.

[0021] US patent 2008267890 protects a composition comprising a C8 to C24 polyunsaturated fatty acid, such as linolenic acid or an ester thereof, and terpinen-4-ol or a derivative thereof. The composition has broad-spectrum antibacterial activity.

[0022] Chinese patent CN102657801 relates to a disinfectant for dairy cow udders. The organic disinfectant is characterized by the following formula: glycerol (concentration >99%) 0.25% to 1%, synthetic Chinese herbal medicine concentrate 0.25% to 1%, and the remainder deionized water. The Chinese herbal medicine concentrates are extracts of honeysuckle, daqingye, diding, geranium, atractylodes, artemisia argyi, yexiazhu, dandelion, sophora flavescens, sarsaparilla, cnidium, pathnia, and senecio. Through cleaning, extraction, re-extraction of the mother liquor, synthesis, decolorization, and concentration, a concentrate with a density > 1.04 g / mm³ is obtained. 3The disinfectant solution of the present invention is directed at the inflammation of the udder of dairy cows caused by the invasion of multiple microorganisms such as Candida albicans and Escherichia coli.

[0023] US patent 20100151053 protects a foaming aerosol solution for disinfecting surfaces. The dipping solution consists of a mixture of carbon dioxide and nitrous oxide in a sealed container. After the liquid dipping solution is expelled through a nozzle, foam is generated upon contact with the surface. The aerosol can be applied to various surfaces. In one embodiment of the invention, the aerosol can be applied to cows' udders without risk of cross-contamination of the nozzle or other equipment. The generated foam remains intact on the udder for an extended period, increases the contact area of ​​the udder with the foam during treatment, and disperses the conditioning fats present in the dipping solution, thereby increasing the coverage of the conditioner on and within the udder epidermis and surrounding areas.

[0024] Mexican patent MX2017016872 protects a sprayable, film-forming aqueous antimicrobial composition comprising, in an aqueous base: (a) a film-forming polymer; (b) an antimicrobial agent; (c) a hydrophobically modified ethoxylated urethane as a tert-modifier; and (d) optionally, an antifoaming agent. Furthermore, the present invention relates to the use of the composition for controlling mastitis in dairy animals and to a method for controlling mastitis in dairy animals comprising spraying the composition onto a teat.

[0025] Among other similar technologies, none of the documents found consider the integrated parameters used in this proposal, nor do any of these documents reproduce the proposed technology, either partially or completely.

[0026] BRIEF DESCRIPTION OF THE FIGURES

[0027] Figure 1: Graph of Bactericidal Efficacy of terpene dipping (0.4%) for 24 hrs. on A) E. coli ATCC 25922 and B) S. aureus ATCC 25923.

[0028] Figure 2: Graph of Bactericidal Efficacy of terpene dipping (0.4%) in the absence and presence of organic matter (5% BSA) for 24 hrs. on A) E. coli ATCC 25922 and B) S. aureus ATCC 25923.

[0029] Figure 3: Graph of Bactericidal Efficacy of terpene dipping at 0.4% and 0.8% for 90 min. On S. aureus ATCC 25923.

[0030] Figure 4: Representative SEM image of biofilm from bacterial strains obtained from the teats of farm cows in the Biobío Region. A) S. aureus, B) E. coli. Figure 5: TEM image of Escherichia coli 6326 from cows exposed to terpene dipping. A) Healthy cell wall. B to D) Damaged cell wall.

[0031] Figure 6: Photograph assessing the condition of the teat of cows exposed to iodophor dipping and terpene dipping. A, C, and D) Teats with dry skin, cracks, and open teat ends. B) Smooth and healthy teat after terpene dipping application.

[0032] Figure 7: Graph of new cases of Intramammary Infections (IIMs): iodophor dipping (control) vs. terpene dipping (experimental), over time.

[0033] DESCRIPTION OF THE INVENTION

[0034] The present invention relates to a terpene-based antiseptic formulation used as a post-milking dip for the prevention and treatment of intramammary infections and subsequent bovine mastitis, as well as for the treatment of skin lesions. This formulation comprises a mixture of terpenes that exhibit antibacterial activity and can be used to prevent, treat, or control intramammary infections in dairy animals.

[0035] The formulation is administered in gel or aqueous form and comprises as its active ingredient, at least, a mixture of terpenes, composed of pinenes, dipentenes, and, primarily, alpha-terpineol.

[0036] This mixture of terpenes is obtained from the desulfurization of turpentine to sulfate, which is a byproduct of the cellulose industry.

[0037] This product is effective primarily against bacterial strains of Staphylococcus aureus as a representative of Gram-positive bacterial species and Escherichia coli as a representative of Gram-negative species, among others, which predominate in intramammary infections with the subsequent generation of mastitis and skin lesions.

[0038] The formulation of this product includes, at least: thymol, alpha-terpineol, and limonene. The product aims to achieve greater effectiveness than current post-milking dips, which are mostly iodine-based, resulting in lower somatic cell counts, lower monthly incidence, and lower prevalence. Halogenated active ingredients tend to be inactivated in the presence of organic matter, and in the case of post-milking, milk remains on the teat, which affects the performance of these dips.

[0039] The post-milking terpene dip gel is applied after milking dairy cows to prevent intramammary infections, which can lead to mastitis. It is also used to treat mastitis and skin lesions. The active ingredient is a mixture of terpenes, the main ones being alpha-terpineol and thymol. It was designed to be used with a dip applicator, a small bottle with a cup for applying the gel to the teat. The terpene dip can be adapted for use in robotic dairy farming, as the active ingredient has proven effective against bacteria even in aqueous solution. The gel, without the active ingredient, was shown to have no effect on the bacteria tested. In vitro tests in veterinary applications demonstrated effectiveness against S. aureus and E. coli (Figures 1 to 3).

[0040] Nowadays, the dipping solution used is iodine, which is very irritating to the skin.

[0041] The gel formulation is used both preventively and for the treatment of intramammary infections, including the more complex clinical mastitis, as well as for application to skin lesions. Its main advantages include its effectiveness in the presence of organic matter, its longer-lasting effect on the skin (since the gel format adheres better), its non-irritating properties, and its effectiveness against bacteria and biofilms.

[0042] The formulation comprises a mixture of terpenes, predominantly pinenes, dipentenes, and, primarily, alpha-terpineol. This mixture is obtained from the desulfurization of turpentine, a byproduct of the pulp and paper industry.

[0043] This technology focuses on the fact that the terpene mixtures obtained have proven to be highly effective against bacteria. The product derived from this formulation exhibits high antibacterial effectiveness. Among its antibacterial effectiveness, its ability to combat the biofilm formed by some bacteria stands out, both through inhibition and removal of pre-formed biofilm. This characteristic reduces the microbial load in critical environments. This is illustrated in Figure 4, which shows a biofilm of bacterial strains obtained from cow teats.

[0044] This technology offers an effective, efficient, and economical product. It overcomes the biofilm barrier, reduces the bacterial load in the animal's udder, thus preventing intramammary infections that can later lead to mastitis, and remains effective hours after application.

[0045] Among the most notable benefits are:

[0046] -High effectiveness: The product has a high biocidal capacity against bacteria that generate biofilms.

[0047] - Low toxicity: The product exhibits low toxicity and does not contain irritating or toxic components such as iodine. The active ingredients are listed as safe in both the Codex Alimentarius and the European Medicines Agency, as they have no Maximum Residue Limit, are natural components of the diet, can be used as food additives, are rapidly metabolized and excreted, and any residues that may remain in animal-derived products are not of toxicological concern to humans.

[0048] - Low cost: The resulting product is low cost, made with natural and abundant raw materials.

[0049] - Reduction of intramammary infections: Reducing these infections helps prevent losses in the agricultural and livestock sector, since mastitis leads to decreased milk production and can even result in the animal's death. The economic benefits, both from reduced costs and the lower rate of intramammary infections, directly help dairy farms of all types of animals that contribute to the agricultural and livestock sector (cattle, goats, horses, etc.).

[0050] The formulation comprises, at least:

[0051] Component Function Percentage mass / mass Terpene mixture Active ingredient 0.1 -4

[0052] Thymol Active ingredient 0.01 - 4

[0053] Glycerin Humectant 1 - 20 Polyvinylpyrrolidone (PVP Gelling Agent) 0.1 - 5

[0054] K30)

[0055] Non-ionic copolymer Surfactant 0.1 - 5 (Poloxamer 407)

[0056] Gelling Xanthan Gum 0.1 - 5

[0057] D&C Red Dye No. 0.0001 - 0.01 Purified Water qspcsp

[0058]

[0059] The components are mixed and a terpene-based gel is obtained.

[0060] This terpene dip is applied after milking. The gel is ready to use, undiluted. For external use only.

[0061] The gel is applied to the cow's teat skin, from base to tip, using a dipper, immediately after removing the milking unit. Any remaining product is discarded, and the dipper is cleaned after the milking process is complete. APPLICATION EXAMPLES

[0062] Example No. 1: Preparation of the gel formulation.- From desulfurization processes of turpentine, which comes from the cellulose industry, a mixture of terpenes was obtained, which contains a low concentration of S (4.5 ppm).

[0063] A formula was developed as follows:

[0064] Component Function Percentage mass / mass Terpene mixture Active ingredient 0.363

[0065] Thymol Active ingredient 0.0363 Glycerin Humectant 10

[0066] PVP K30 Gelling Agent 1

[0067] Poloxamer 407 Surfactant 0.25

[0068] Xanthan Gum Gelling Agent 0.5

[0069] D&C Red Dye No. 0.08

[0070] Purified water cspcsp

[0071]

[0072] The formula was prepared as follows:

[0073] 1) First, both active ingredients are combined until the thymol is completely dissolved in the terpene mixture.

[0074] 2) Then, in a container with stirring, add until completely dissolved:

[0075] Water, Xanthan Gum, PVP K30, Poloxamer 407, Glycerin, Active Ingredients, Colorants.

[0076] Example No. 2: Evaluation of bactericidal effectiveness. - The bactericidal efficacy of an antiseptic formulated as a terpene dip for post-milking application was evaluated. The antiseptic is composed of gelling agents, humectants, colorants, and a terpene-based active ingredient. The methodology recommended by the Public Health Institute of Chile (ISP, 2023) was used, employing the bacterial strains Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923. A phosphate-buffered saline (PBS) solution, pH 7.4, was used as a bacterial viability control.

[0077] In addition, the bactericidal efficacy of all dipping components was evaluated in the absence of the terpene-based active ingredient, which was designated as the S / PA control. Bactericidal efficacy was determined using the quantitative microdroplet counting method (Strahsburger et al., 2016). At each sampling time, the bacterial count was determined by counting between 20 and 80 colonies and multiplying by the dilution factor. Each determination was performed in triplicate, and the bacterial count was expressed in CFU / ml. The sampling times were: 0 h, 0.008 h (30 s), 0.017 h (1 min), 0.083 h (5 min), 1 h, 6 h, and 24 h.

[0078] The Shapiro-Wilk and Kolmogorov-Smirnov tests were applied to evaluate the type of data distribution, revealing a non-normal (non-Gaussian) distribution (α-value + 0.05). Therefore, the non-parametric Mann-Whitney U test was subsequently used to determine the statistical significance of the data. All three tests were performed using GraphPad Prism v10.3.0 software.

[0079] Figure 1A) clearly shows the rapid bactericidal action of terpene dipping at a concentration of 0.4% against E. coli. Figure 1B) shows the same bactericidal action against S. aureus, but this occurs somewhat more slowly, with its effects visible after 6 hours.

[0080] In Figure 2, the effect of terpene dipping at 0.4% and 0.8% on S. aureus is observed, where it can be seen that the higher the concentration of terpene dipping, the faster the bactericidal action on S. aureus.

[0081] Furthermore, the minimum inhibitory concentration (MIC) of the terpene, surfactant, and water mixture was established at 0.039% for both pathogens in the laboratory study, and it was also established that the surfactant does not influence pathogen mortality. Example No. 3: Evaluation of bactericidal effectiveness in the absence and presence of organic matter. - For the study of bactericidal efficacy in the presence of organic matter, the recommendations provided by ISP (2023) were followed, for which 5% bovine serum albumin (BSA) was used.

[0082] In this case, the sampling times were: 0, 1 min, 3 min, 5 min, 10 min, 20 min, 30 min, 45 min, 60 min, and 90 min. In all experiments, before performing the bacterial count, the residual antibacterial effect of the terpene dipping was neutralized using Dey-Engley neutralizing broth, following the manufacturer's recommendations.

[0083] The results of bacterial counts (CFU / mL) obtained during the evaluation of the effectiveness of the formulated terpene dipping solution, in the absence and presence of organic matter (5% BSA), show that the formula exhibits a very rapid bactericidal action against the E. coli ATCC 25922 strain, achieving a 5-log reduction between 30 s and 1 min (Figure 3A). In contrast, for S. aureus ATCC 25923, this effect was slower, with a 5-log reduction observed between 5 min and 1 h (Figure 3B).

[0084] Regarding the presence of organic matter (5% BSA), it can be observed that the bactericidal action of the formula against E. coli ATCC 25922 and S. aureus ATCC 25923 was not affected by its presence. In the case of E. coli ATCC 25922, the two bacterial count curves over time overlapped, with no significant difference between the values ​​(α > 0.9999). In the case of S. aureus ATCC 25923, it was observed that the bactericidal effectiveness was slightly delayed in the presence of 5% BSA, as the 5-log reduction was reached at 1 h. However, the statistical analysis indicated that there were no significant differences between the CFU / ml values ​​obtained in the presence and absence of 5% BSA (α = 0.5629).

[0085] Figure 4 shows, under electron microscopy, a biofilm of bacterial strains obtained from the teats of farmed cows in the Biobío Region. A) S. aureus, B) E. coli. Figure 5 shows bacteria obtained directly from cows exposed to terpene dipping. A) shows bacteria with a healthy cell wall. Figures B to D) show bacteria with damaged cell walls.

[0086] Example No. 4: Evaluation of potential skin irritation.- This formulation was tested on cows to analyze potential skin irritation. The skin health of 3 cows was evaluated by applying the product to each quarter, with checks at 30 minutes, 1 hour, and 6 hours. No irritation was observed, and good overall skin health was maintained.

[0087] Example No. 5: Evaluation of bactericidal effectiveness in cows under normal milking and living conditions. - An experiment was designed to evaluate the impact of a treatment on mastitis with high reliability, ensuring that the observed differences are due to the treatment and not to the animal's pre-existing characteristics (Ceballos-Marquez et al., 2013; Godden et al., 2016). This was authorized by the Agricultural Research Institute, INIA.

[0088] In vivo bactericidal effectiveness tests were performed on cows in a real habitat under normal milking conditions.

[0089] - Selection and recruitment criteria for cows in the study: 180 cows were selected. Based on visual inspection of the cow and udder, they appeared healthy and had not received antibiotic or anti-inflammatory treatments during the 30 days prior to their participation in the study. The selected cows shared a pasture-based production system with equivalent feeding and management practices, and a twice-daily milking schedule. The groups were balanced by parity (1, 2, >3), days in milk (DIM) within the range of 5 to 305 days, and infection status at the start of the trial (Somatic Cell Count, SCC: SCC <100,000 cells / mL, SCC <200,000 cells / mL).Furthermore, the conditions for replacing those animals that, for various production reasons, had to abandon lactation and their experimental group were considered; for this purpose, new animals were incorporated into the study in a balanced way, the latter having to meet the incorporation requirements mentioned above, while their risk of infection was evaluated considering, correspondingly, the variable of "weeks of stay" within the evaluation of teat risk month of the experimental design.

[0090] The cows selected with these requirements were classified into 2 groups:

[0091] Group 1: Positive control group with application of iodophor dipping (Della Barrier® DeLaval) n = 90

[0092] Group 2: Experimental group with terpene dipping application n= 90

[0093] The total study time was 14 weeks, in order to obtain sufficient testing power to validate the experimental design used, based on the incidence of natural intramammary infections that have been historically reported for the herd, based on its pond somatic cell count and estimated prevalence (infection pressure).

[0094] - Handling of experimental product and positive control

[0095] Before the start of the trial, study personnel were trained on both general and study-specific procedures related to good hygiene and milking routines. Color-coded bands corresponding to each group were placed on the leg of each cow: Positive control group (yellow bands) and experimental group (orange bands). The dippiness dispensers were also color-coded (orange and yellow) to ensure the correct post-milking product treatment was applied. Feeding and general animal management were the same for both groups. Personnel were supervised during all milkings by trained staff. Bacterial isolation from milk samples was performed.

[0096] Initially, samples were taken for individual microbiological culture from each functional mammary quarter of all cows enrolled in the study (n = 180 cows). Previous estimates considered 95% of functional mammary quarters (n = 700 quarters). The samples were sent to a private laboratory for microbiological culture. This allowed for initial testing to evaluate the prevalence of intramammary infections (IMIs) in the entire group of animals, complementing the individual somatic cell count (SCC) assessment. The potential existence of culture-positive quarters was evaluated in multiparous cows with composite SCC values ​​below 200,000 cells / mL.

[0097] Biweekly (or bimonthly) sampling was performed on all quarters of each cow enrolled in the study. A composite milk sample was extracted from all four mammary quarters (using the proportional / Waikato meter) for individual somatic cell count (SCC) assessment per cow. Milk samples were transported in sampling vials provided by the analytical laboratory.

[0098] In this same bi-weekly sampling, each sample that showed a somatic cell count above the threshold (SCC < 100,000 cells / mL for heifers and SCC < 200,000 cells / mL for cows) required culture of all four quarters: cows that showed recovery (high-low count), chronic cows (high-high count), and cows with new infections (low-high count). In cases where the milk sample for microbiological culture was contaminated, this sampling had to be repeated to correctly classify the quarters of that cow.

[0099] In the event that an affected cow or heifer (SCC above the threshold, > 200,000 cells / mL or > 100,000 cells / mL, respectively) presented a negative culture from all four quarters, the Laboratory was asked to perform testing for the isolation and specific identification of Mycoplasma bovis. Along with the aforementioned samplings, a total of 14 total (weekly) bulk tank milk samples were also taken to evaluate the microbiological profile of the entire group of animals participating in the study. A duplicate of this bulk tank sample was frozen for subsequent shipment to the Faculty of Pharmacy at the University of Concepción for bromatological analysis.

[0100] The mean SCR of the control group was 145,100 cells / ml, while the mean SCR of the study group was 111,100 cells / ml. This translates to a mean SCR of the control group that was 30.6% higher compared to the mean of the study group.

[0101] - Nipple condition assessment

[0102] To evaluate the emollient function of the experimental formulation, a complete visual assessment of the teats was performed on all animals in the study. This was done to record the initial condition of both the skin and teat tip before the start of the study and the application of both products (control dip and terpene dip). Subsequently, the condition of the teats was recorded every two months to assess the maintenance, improvement, or deterioration of skin and teat tip quality during the weeks alternating with the somatic cell count (SCC) and microbiological culture assessments. If teat skin deterioration was observed in the experimental group, the study would be suspended due to the potential impact on the welfare of the cows assigned to this group. The evaluation procedures were performed according to the guidelines described in “Guidelines for Evaluating Teat Skin Condition” (NMC, 2007).

[0103] The evaluations showed that the nipples, which were regularly subjected to iodophor dipping and were found to be dry and in a suboptimal skin condition, once the study began, from day 3, were seen to be smooth and healthy again and remained so for at least 12 weeks.

[0104] Figure 6 shows the evaluation of teat condition in cows exposed to terpene dipping. A, C, and D) Teats with dry-appearing skin, fissures, and open teat tips with mild hyperkeratosis. B) Healthy teat, post-terpene dipping application.

[0105] - Statistical analysis

[0106] The incidence of new IIMs during the study was calculated as the number of new IIMs divided by the number of rooms at risk for a new IIM, across all sampling points. The efficacy of the disinfectant products was evaluated in terms of the reduction in the rate of new infections observed in rooms disinfected with the experimental product, compared to the rate observed in rooms disinfected with the control product. A 95% confidence interval (CI) was used in the evaluation of the non-inferiority of the products. The probability of new IIMs was evaluated using a logistic regression model, while the rate of new infections in both animal groups was evaluated using a Poisson regression model.

[0107] Definition of a new IIM case: An increase in the composite SCC threshold of a cow, with single-quarter isolation and positive culture confirmation, is considered a new IIM case in this study. Alternatively, a new IIM is also considered in cases of previously high SCC where the pathogen isolated in the single-quarter culture is different from the pathogen isolated associated with the mammary quarter IIM in the previous evaluation.

[0108] A rate of new cases of IIMs was established

[0109] - Experimental Group (terpene dipping): Presented an average of 6.71 new cases per measurement. A fluctuation in cases was observed, reaching its maximum in week 12 (12 cases).

[0110] - Control Group (Iodophor Dipping): Presented an average of 7.00 new cases per measurement, with its peak in week 10 (12 cases). To validate whether the type of dipping influenced the appearance of new infections, a Student's t-test for independent samples was applied. Result p-value: 0.874

[0111] Since the p-value is significantly higher than the standard threshold of 0.05, it is determined that there is no statistically significant difference in the incidence of IIMs between the two groups, under the same milking and management conditions. This suggests the following:

[0112] There is equivalent efficacy; that is, the terpene dip has a similar performance to the control dip (with iodophor) in controlling pathogens for both the 1% iodine dip and the 0.4% terpene dip. (Figure 7) Environmental Influence: Since the cows went to milking together and shared the same environment, the infection pressure was uniform for both groups. The variation observed in weeks 10 and 12 in both groups, respectively, would be due to seasonal factors and / or general herd management rather than the effect of the sealant.

[0113] Figure 7 shows a graph of new cases of intramammary infections (IMIs): iodophor dipping (control) vs. terpene dipping (experimental), over time. It shows that both dipping methods exhibit a similar pattern over time with respect to new cases of IMIs.

[0114] - Analysis of Microbiological Findings and Prevalence of Pathogens 1,236 microbiological cultures were analyzed and revealed a distribution of pathogens that allowed characterizing the health challenge of both groups under the same management conditions.

[0115] A prevalence of 2.33% (15 cases) of Staphylococcus aureus was identified exclusively in the experimental group, while the control group showed no isolates of this pathogen. This difference is relevant for monitoring segregation during milking. Both groups showed an almost identical incidence (Control: 13.54%; Experimental: 13.02%) of coagulase-negative Staphylococcus (CNS). These results suggest a uniform infection pressure from opportunistic / environmental pathogens in the herd, independent of the type of milking seal.

[0116] The presence of Streptococcus dysgalactiae remained low in both groups (<1.3%), while S. equinus showed a higher frequency in the control group (1.86%) compared to the experimental group (0.78%).

[0117] Furthermore, Corynebacterium bovis was the main isolate throughout the study, with a prevalence of 36.72% in the control group and 37.98% in the experimental group. As a classic marker of teat sealing effectiveness with the dippinera, its high and balanced presence confirms that both groups were subjected to an equivalent technical and environmental challenge.

[0118] Finally, the rate of cultures without bacterial growth (negative samples) was 45.85% for the control and 43.10% for the experimental, which validates the overall stability of breast health in the evaluated population.

[0119] The data indicated no drastic variations in the overall microbiological profile between the groups, except for the focal appearance of S. aureus in the experimental group. The high correlation in the incidence of SCN and C. bovis between both groups supports the validity of the experimental design, confirming that the animals shared a similar level of exposure to pathogens in the milking parlor environment.

[0120] - Therapeutic range trial

[0121] A 10-day study was conducted in which the terpene group was given an experimental dip at a concentration five times higher than the dip used in the study. During the 10 weeks, no cows showed any signs of teat irritation or damage due to the increased concentration, allowing for use at concentrations above the therapeutic range. Terpene transfer to the milk was also measured, and no terpene was detected in milk at concentrations above 10 ppb. General trial conditions

[0122] It should be mentioned that there are situations that occur in conventional dairies, such as:

[0123] - The teats, even after being washed pre-milking, could still be dirty with mud or feces.

[0124] - Dippinera are normally exposed to: water, urine, flies, and to a lesser extent, feces.

[0125] The placement of the dipper is important because it determines how much the product falls during the test. In this context, the terpene dipper fell less than the iodine dipper in all phases of the process.

[0126] All animal handling and disinfectant procedures in the study were performed using the guidelines established by the NMC (USA), www.nmconline.org “National Mastitis Council Guidelines: Testing of Teat Disinfectants for Efficacy in Preventing Intramammary Infections”.

Claims

CLAIMS 1. Post-milking dipping antiseptic formulation for the prevention and treatment of intramammary infections CHARACTERIZED in that the formulation comprises at least: a. Active ingredient based on a terpene mixture, obtained from a by-product of the cellulose industry. b. Active ingredient Thymol, c. Humectant, d. Gelling agent, e. Surfactant, f. Dye and g. Water, in sufficient quantity.

2. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that the terpene mixture base comprises at least alpha-terpineol, limonene and thymol.

3. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that the terpene mixture is obtained from the desulfurization of turpentine to sulfate.

4. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that the terpene mixture is used at a concentration of 0.1 to 4% w / w, preferably 0.363% w / w.

5. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that the active ingredient Thymol is used at a concentration of 0.01 to 4% w / w, preferably 0.0363% w / w.

6. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that the wetting agent used is at a concentration of 1 to 20% w / w, preferably 10% w / w.

7. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that at least two gelling agents are used, polyvinylpyrrolidone and / or xanthan gum, both at a concentration of 0.1 to 5% w / w, preferably 1% and 0.5% w / w, respectively.

8. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that the surfactant used is a non-ionic block copolymer at a concentration of 0.1 to 5% w / w, preferably 0.25% w / w.

9. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that the colorant is used at a concentration of 0.0001 to 0.01% w / w, preferably 0.08% w / w.

10. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that the formulation has a bactericidal action at a concentration between 0.01 to 2.0%, preferably 0.4 to 0.8% 11. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that the formulation has a bactericidal action against pathogens, preferably Escherichia coli and Staphylococcus aureus.

12. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that the formulation begins to have its bactericidal effect from 5 minutes after its application.

13. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that the formulation has bactericidal effectiveness in the absence and presence of organic matter.

14. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that the formulation recovers the skin and teat tip in at least three days and keeps it healthy for at least twelve weeks.

15. Post-milking dipping formulation, according to claim No. 1, CHARACTERIZED in that the terpene mixture does not pass into the milk.

16. A method for obtaining a post-milking dipping antiseptic formulation for the prevention and treatment of intramammary infections, CHARACTERIZED in that the method comprises: a) First, combine both active ingredients until the thymol is completely dissolved in the terpene mixture. b) Second, in a container with stirring, the rest of the components are added until completely dissolved.

17. A use of a post-milking dipping antiseptic formulation for the prevention and treatment of intramammary infections CHARACTERIZED in that it is used in different milk-producing animals, preferably cattle, goats, horses.

18. A dipping-type formulation use, according to claim No. 14, CHARACTERIZED in that the form of administration is preferably in gel and / or aqueous form.

19. A dipping-type formulation use, according to claim No. 14, CHARACTERIZED in that it is used externally.